Age- and Sex-specific Reference Values for Fasting Serum Insulin Levels and Insulin Resistance/sensitivity Indices in Healthy Iranian Adults: Tehran Lipid and Glucose Study
Overview
Authors
Affiliations
Objectives: Increased insulin concentration is a surrogate for insulin resistance and early assessment of fasting insulin may help in identifying those who are potentially at high risk of type 2 diabetes, hypertension, and cardiovascular disease. The aim of this study was to determine age- and sex-related reference values for serum insulin and insulin resistance/sensitivity indices in Iranian subjects.
Design And Methods: Serum insulin levels were measured by electrochemiluminescence immunoassay in 5786 participants of the Tehran Lipid and Glucose Study. After application of exclusion criteria, 309 non-obese healthy subjects (124 men and 185 women), aged 24-83 y, were included. The International Federation of Clinical Chemistry guidelines (non-parametric method) and the robust method were used for determining reference values.
Results: Overall 95% reference values for fasting insulin were 1.61-11.37, 2.34-11.98, and 2.11-12.49 μU/mL in men, women, and total population respectively. Mean fasting insulin concentration showed a decreasing trend with age in both genders (p for trend ≤0.001). Age, waist circumference, and systolic blood pressures were biological determinants of fasting insulin in both genders; in addition, insulin was modulated by triglycerides in men and fasting glucose in women. Reference intervals for HOMA1-IR, HOMA2-IR, and QUICKI were 0.63-2.68, 0.40-1.80, and 0.33-0.42, respectively.
Conclusion: This study presents the first set of reference values for fasting serum insulin to be 2-12 μU/mL for both genders in a healthy sample of Iranian adults along with the reference values for insulin resistance/sensitivity indices. These values could be used for identifying subjects with insulin resistance in epidemiological and clinical research.
Bahadoran Z, Kashani Z, Mahdavi M, Mirmiran P, Azizi F Eur J Med Res. 2025; 30(1):110.
PMID: 39962610 PMC: 11834172. DOI: 10.1186/s40001-025-02337-5.
Bahadoran Z, Ghafouri-Taleghani F, Azizi F, Ghasemi A Biol Trace Elem Res. 2025; .
PMID: 39939554 DOI: 10.1007/s12011-025-04545-w.
Bahadoran Z, Mirmiran P, Ghasemi A, Azizi F J Diabetes Metab Disord. 2024; 24(1):8.
PMID: 39697867 PMC: 11649602. DOI: 10.1007/s40200-024-01517-0.
Masumi M, Bahadoran Z, Mirmiran P, Khalili D, Sarvghadi F, Azizi F BMC Public Health. 2024; 24(1):3143.
PMID: 39533278 PMC: 11559074. DOI: 10.1186/s12889-024-20680-w.
Schrank Y, Fontes R, Perozo A, Araujo P, Pinheiro M, Gomes D Arch Endocrinol Metab. 2024; 68:e230483.
PMID: 39529982 PMC: 11554367. DOI: 10.20945/2359-4292-2023-0483.